The 36-month beta value for ACCD is also noteworthy at 1.99. There are mixed opinions on the stock, with 5 analysts rating it as a “buy,” 6 rating it as “overweight,” 6 rating it as “hold,” and 0 rating it as “sell.”
The public float for ACCD is 69.12M, and at present, short sellers hold a 7.03% of that float. The average trading volume of ACCD on October 16, 2024 was 1.24M shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ACCD) stock’s latest price update
Accolade Inc (NASDAQ: ACCD)’s stock price has soared by 2.18 in relation to previous closing price of 3.67. Nevertheless, the company has seen a loss of -7.18% in its stock price over the last five trading days. prnewswire.com reported 2024-10-15 that Partnership will drive cost savings for customers while providing high-touch services that improve health outcomes to members with chronic kidney disease (CKD). SEATTLE, Oct. 15, 2024 /PRNewswire/ — Accolade, Inc. (Nasdaq: ACCD) today announced that Renalogic, the recognized industry leader that manages the human and financial costs of chronic kidney disease (CKD) for self-insured employers and their members, will join the company’s Trusted Partner Ecosystem, to offer its proven CKD risk management and dialysis cost containment solutions.
ACCD’s Market Performance
Accolade Inc (ACCD) has seen a -7.18% fall in stock performance for the week, with a -10.93% decline in the past month and a -2.34% plunge in the past quarter. The volatility ratio for the week is 6.19%, and the volatility levels for the past 30 days are at 5.77% for ACCD. The simple moving average for the last 20 days is -3.10% for ACCD’s stock, with a simple moving average of -49.16% for the last 200 days.
Analysts’ Opinion of ACCD
Many brokerage firms have already submitted their reports for ACCD stocks, with Needham repeating the rating for ACCD by listing it as a “Buy.” The predicted price for ACCD in the upcoming period, according to Needham is $8 based on the research report published on June 28, 2024 of the current year 2024.
Leerink Partners, on the other hand, stated in their research note that they expect to see ACCD reach a price target of $16. The rating they have provided for ACCD stocks is “Outperform” according to the report published on February 26th, 2024.
DA Davidson gave a rating of “Neutral” to ACCD, setting the target price at $14 in the report published on January 17th of the current year.
ACCD Trading at -6.34% from the 50-Day Moving Average
After a stumble in the market that brought ACCD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -75.59% of loss for the given period.
Volatility was left at 5.77%, however, over the last 30 days, the volatility rate increased by 6.19%, as shares sank -12.99% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +3.02% upper at present.
During the last 5 trading sessions, ACCD fell by -7.18%, which changed the moving average for the period of 200-days by -70.82% in comparison to the 20-day moving average, which settled at $3.87. In addition, Accolade Inc saw -68.78% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ACCD starting from Barnes Stephen H., who sale 228 shares at the price of $3.77 back on Oct 11 ’24. After this action, Barnes Stephen H. now owns 203,048 shares of Accolade Inc, valued at $860 using the latest closing price.
Cavanaugh Robert N, the President of Accolade Inc, sale 217 shares at $3.77 during a trade that took place back on Oct 11 ’24, which means that Cavanaugh Robert N is holding 197,202 shares at $818 based on the most recent closing price.
Stock Fundamentals for ACCD
Current profitability levels for the company are sitting at:
- -0.21 for the present operating margin
- 0.43 for the gross margin
The net margin for Accolade Inc stands at -0.18. The total capital return value is set at -0.14. Equity return is now at value -18.61, with -9.95 for asset returns.
Based on Accolade Inc (ACCD), the company’s capital structure generated 0.34 points at debt to capital in total, while cash flow to debt ratio is standing at 0.04. The debt to equity ratio resting at 0.51. The interest coverage ratio of the stock is -28.29.
Currently, EBITDA for the company is -62.99 million with net debt to EBITDA at -0.95. When we switch over and look at the enterprise to sales, we see a ratio of 0.77. The receivables turnover for the company is 17.49for trailing twelve months and the total asset turnover is 0.58. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.68.
Conclusion
In summary, Accolade Inc (ACCD) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
